Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-06-10
1988-03-22
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548359, A61K 31415, C07D23154
Patent
active
047329092
ABSTRACT:
3-(3-Halophenyl)-3,4-diazatetracyclo-[6.3.1.1.sup.6,10.0.sup.1,5 ]tridec-4-en-2-ones are useful as anti-hypoxia agents.
REFERENCES:
Stetter et al., "1,2 Diamines of Adamantane, Homoadamantane and Noradamantane" (German, with English abstract) Justus Liebigs Ann. Chem., (6) 999-1004 (1977).
Armarego et al., "The Synthesis of 3.5 Diazatetracyclo[7.3.1.1.sup.7,11 0.sup.1,6 ]-tetradecanes" Aust. J. Chem., vol. 31, 1769-1775 (1978).
Moiseev et al., "Admantane and its Derivatives: 1.Hydrazones and Pyrazolones of Adamantane" Khim. Geterotskil. Soedin., (4), 528-531 (1982).
Georgiev Vassil S.
Mullen George B.
Swift Patricia A.
Briscoe Kurt G.
Jiles Henry R.
Pennwalt Corporation
LandOfFree
3-(3-halophenyl-3,4-diazatetracyclo-[6.3.1.1.sup.6,10.0.sup.1,5 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(3-halophenyl-3,4-diazatetracyclo-[6.3.1.1.sup.6,10.0.sup.1,5 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(3-halophenyl-3,4-diazatetracyclo-[6.3.1.1.sup.6,10.0.sup.1,5 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442319